117P - Anti-HER2 therapy efficacy in HER2-negative metastatic breast cancer with HER2-amplified circulating tumor cells: results of the CirCe T-DM1 trial

Autor: Bidard, F-C., cottu, P., Dubot, C., Venat-Bouvet, L., Lortholary, A., Bourgeois, H., Bollet, M., Servent Hanon, V., Luporsi-Gely, E., Espie, M., Guiu, S., D'Hondt, V., Diéras, V., Sablin, M.P., Neffati, S., Berger, F., Pierga, J-Y., Jacot, W.
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v32-v32
Databáze: ScienceDirect